重组人VAP-1(血管黏附蛋白1)(膜伯胺氧化酶)北京厂家

特别声明：本产品及我公司所售其他产品均为科研类试剂产品，严禁用于药物、医疗及其他非科研用途。

北京百奥莱博主要从事生物试剂的生产和销*(代"售")，产品线涵盖重组人VAP-1(血管黏附蛋白1)(膜伯胺氧化酶)北京厂家在内的分子生物学试剂产品，还包括PCR及荧光定量PCR、核酸提取试剂盒类、样本核酸保护试剂、核酸提取、克隆与转化、蛋白纯化、蛋白检测、免疫组化、细胞凋亡与抗体等。

名称：重组人VAP-1(血管黏附蛋白1)(膜伯胺氧化酶)北京厂家
英文名：Recombinant Human Membrane Primary Amine Oxidase
品牌：百奥莱博
编号：JN0768
产地：国产|进口
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Arg27-Asn763在C端含有His标签。

VAP-1/AOC3质量控制：＞95%(还原性SDS-PAGE)

VAP-1/AOC3制剂：液体

VAP-1/AOC3保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。

关于VAP-1/AOC3：
Vascular adhesion protein-1(VAP-1) is a copper amine oxidase with a topaquinone cofactor.VAP-1 is a type II integral membrane protein, but a soluble form of the enzyme is present in human serum, and its level increases in diabetes and some inflammatory liver diseases. VAP-1 catalyzes the oxidative deamination of small primary amines such as methylamin*(代"e"), benzylamine, and aminoacetone in a reaction that produces an aldehyde, ammonia, and H2O2. VAP-1 vascular expression is regulated at sites of inflammation through its release from intracellular granules in which the protein is stored. The adhesive function of VAP-1 has been demonstrated in studies showing that the protein is important for the adherence of certain lymphocyte subtypes to inflamed endothelial tissues. VAP-1 mediated adhesion is involved in the process of leukocyte extravasation, an important feature of inflammatory responses. VAP-1 is considered to be a therapeutic target for diabetes, oxidative stress, and inflammatory diseases.

我公司的重组人VAP-1(血管黏附蛋白1)(膜伯胺氧化酶)北京厂家，性价比高，货期短，送货上门，欢迎您来电咨询购买，另外，我公司还生产供应销*(代"售")下列产品：

·重组小鼠EDA2R(TNFRSF27)(XEDAR)
编号：JN0493
英文名称：Recombinant Mouse Ectodysplasin A2 Receptor
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Met1-Thr138在C端含有His标签。

EDA2R/TNFRSF27/XEDAR 质量控制：＞95%(还原性SDS-PAGE)

EDA2R/TNFRSF27/XEDAR 制剂：冻干品

EDA2R/TNFRSF27/XEDAR 保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

EDA2R/TNFRSF27/XEDAR 复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于EDA2R/TNFRSF27/XEDAR ：
Tumor necrosis factor receptor superfamily member 27, also known as XEDAR and EDA2R, is a type III transmembrane protein of the TNFR superfamily. EDA2R consists of extracellular domain (ECD) with 3 cysteine-rich repeats and a single transmembrane domain but lacks an N-terminal signal peptide. EDA2R is widely expressed, notably in embryonic basal epidermal cells and maturing hair follicles. Even though it does not contain a cytoplasmic death domain, EDA2R can associate with Fas and induce EDA‑A2 dependent apoptosis. Its transcription is directly induced by p53, and it mediated cell death is p53 dependent. it is down‑regulated in breast, colon, and lung cancers, particularly in cases with p53 mutations. It also plays a role in EDA‑A2 induced skeletal muscle degeneration and osteoblast differentiation. Mutations in the EDA gene are associated with the X-linked form of Hypohidrotic Ectodermal Dysplasia (HED), a disease typically characterized by abnormal hair, teeth and sweat glands.


重组人VAP-1(血管黏附蛋白1)(膜伯胺氧化酶)北京厂家关键词：重组人血管黏附蛋白1,JN0768,重组人VAP-1,重组人膜伯胺氧化酶,重组人VAP-1蛋白


·重组人Cystatin C(胱抑素C)
编号：JN1630
英文名称：Recombinant Human Cystatin C
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Ser27-Ala146表达纯化得来。

Cystatin C质量控制：＞95%(还原性SDS-PAGE)

Cystatin C制剂：冻干品

Cystatin C保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

Cystatin C复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于Cystatin C：
Cystatin C is a member of family 2 of the cystatin superfamily. It is ubiquitous in human tissues and body fluids and mainly used as a biomarker of kidney function. Cystatin C inhibits many cysteine proteases such as papain and Cathepsins B, H, K, L and S. As an inhibitor of cysteine proteinases, Cystatin C is thought to serve an important physiological role as a local regulator of this enzyme activity. Recently, it has been studied for its role in predicting new-onset or deteriorating cardiovascular disease. It also seems to play a role in brain disorders involving amyloid (a specific type of protein deposition), such as Alzheimers disease.


重组人VAP-1(血管黏附蛋白1)(膜伯胺氧化酶)北京厂家关键词：重组人血管黏附蛋白1,JN0768,重组人VAP-1,重组人膜伯胺氧化酶,重组人VAP-1蛋白


·重组小鼠TNFRSF9
编号：JN0477
英文名称：Recombinant Mouse 4-1BB ligand receptor
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Val24-Leu187在C端带有Fc标签。

TNFRSF9质量控制：＞95%(还原性SDS-PAGE)

TNFRSF9制剂：液体

TNFRSF9保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。

关于TNFRSF9：
Tumor necrosis factor receptor superfamily member 9(TNFRSF9) is a member of the tumor necrosis factor (TNF) receptor family. It can be induced by lymphocyte activation (ILA) and is expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, TNFRSF9 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. As receptor for TNFSF9/4-1BBL, it can activate T cells and the cross-linking of this protein can enhance T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice.

我公司强烈推荐重组蛋白系列产品，热情期待您的咨询选购重组人VAP-1(血管黏附蛋白1)(膜伯胺氧化酶)北京厂家。